Skip to Content

Gold River Productions Inc GRPS

Morningstar Rating
$0.00 0.00 (19.46%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GRPS is trading at a 34% discount.
Price
$0.00
Fair Value
$5.93
Uncertainty
Extreme
1-Star Price
$3.00
5-Star Price
$2.32
Economic Moat
Pbcj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GRPS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.01
Market Cap
$4.12 Mil
Volume/Avg
721,666 / 1.2 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Gold River Productions Inc is a medical cannabinoids company involved in developing products targeting disease states as supplements. The company offers various products including Wrinkle Cream, EnergyPlex CBD, Hemorrhoid Plus CBD, Addiction Kit and Sominoplex-CBD among others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
GRPS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
GRPS
Quick Ratio
0.79
Current Ratio
1.40
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
GRPS
Return on Assets (Normalized)
−31.74%
Return on Equity (Normalized)
−60.27%
Return on Invested Capital (Normalized)
−43.91%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AMwxct$90.3 Bil
MKKGY
Merck KGaA ADRWbhyc$74.8 Bil
HLN
Haleon PLC ADRYttg$38.3 Bil
VTRS
Viatris IncGmjj$16.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRLfzgs$12.9 Bil
CTLT
Catalent IncMvfnrt$10.6 Bil
PRGO
Perrigo Co PLCXdqv$4.4 Bil
CURLF
Curaleaf Holdings IncMskl$3.9 Bil
PBH
Prestige Consumer Healthcare IncPghxgn$3.5 Bil
GTBIF
Green Thumb Industries IncGbdkx$3.4 Bil

Sponsor Center